Austria’s leading biotechnology company, Intercell AG, has agreed to merge with Vivalis SA of France in an all-share transaction that will give Vivalis’s shareholders a controlling stake in a new, combined company to be located in Lyons, France. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
